CLINICAL_TRIALS trial_result · 2018-08-07

Clinical Trial Update: Evaluation of a New Anti-cancer Immunotherapy After Chemotherapy in Adult Patients With Acute Myeloid Leukemia (AML) [Phase 1]

Phase 1 trial evaluating a new anti-cancer immunotherapy after chemotherapy in adults with acute myeloid leukemia has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: GlaxoSmithKline | Conditions: Leukaemia, Myelocytic, Acute | Phase 1 | Status: COMPLETED | Results posted: 2018-08-07